Skip to main content
Leslie Boyd, MD, Obstetrics & Gynecology, New York, NY

LeslieRBoydMD

Obstetrics & Gynecology New York, NY

Gynecologic Oncology

Director, Gynecologic Oncology at NYU Perlmutter Cancer Center Vice Chair of Gynecology, NYU Langone Health

Dr. Boyd is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Boyd's full profile

Already have an account?

  • Office

    240 East 38th Street
    20th Floor
    New York, NY 10016
    Phone+1 212-731-6430
    Fax+1 212-731-5600

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Gynecologic Oncology, 2006 - 2009
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Obstetrics and Gynecology, 2006 - 2009
  • Yale School of Medicine
    Yale School of MedicineClass of 2000

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2003 - 2026
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Journal Articles

  • “Best Practices in Risk Reducing Bilateral Salpingo-Oophorectomy: The Influence of Surgical Specialty”  
    Leslie R Boyd, Yang Long, Dominique R Malacarne, BioMed Central

Authored Content

  • “Really Great News:” Practice-Changing Endometrial Cancer Trial ResultsApril 2023

Press Mentions

  • “Really Great News:” Practice-Changing Endometrial Cancer Trial Results
    “Really Great News:” Practice-Changing Endometrial Cancer Trial ResultsApril 14th, 2023
  • HPV Vaccine Could Shifts Rates of Non-Cervical Cancers
    HPV Vaccine Could Shifts Rates of Non-Cervical CancersJanuary 12th, 2022
  • Sihuan Pharmaceutical (0460.HK): Under Innovation Transformation, an Internationalized New Pattern in Construction
    Sihuan Pharmaceutical (0460.HK): Under Innovation Transformation, an Internationalized New Pattern in ConstructionSeptember 15th, 2020
  • Join now to see all